CG-DIMONO PTX
LIVE

Serial Number

79418477

Owner

CAREGEN CO., LTD.

Attorney

Miriam D. Trudell

Filing Date

Jan 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CG-DIMONO PTX Trademark

Serial Number: 79418477 • Registration: 8081819

CG-DIMONO PTX is a trademark filed by CAREGEN CO., LTD. on January 23, 2025. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

CAREGEN CO., LTD. (31 trademarks)

46-38, LS-ro 91beon-gil,

Entity Type: 03

Trademark Details

Filing Date

January 23, 2025

Registration Date

December 30, 2025

Published for Opposition

November 11, 2025

Goods & Services

Cosmetics; functional cosmetics being skin care preparations; anti-aging cosmetic preparations; wrinkle removing skin care preparations; skin moisturisers; cosmetic preparations for body care; cosmetic preparations for protecting the skin from the sun's rays; cosmetic preparations for skin care; cosmetic preparations for slimming purposes; cosmetic preparations for the hair and scalp; wrinkle-minimizing cosmetic preparations for topical facial use; skin whitening preparations; skin emollients; cosmetic preparations for skin renewal; hair care preparations; mask pack for cosmetic purposes; tissues impregnated with cosmetic lotions; non-medicated facial cleansers; essential oils; perfumery

Injectable dermal fillers; skin hydrators being injectable dermal fillers; injectable dermal fillers for reducing skin wrinkles; pharmacological preparations for skin care; pharmaceuticals containing botulinum toxin for use in the treatment of excessive sweating; pharmaceuticals containing botulinum toxin for use in the treatment of excessive eye blinking; pharmaceuticals containing botulinum toxin for use in the treatment of neuropathy pain; pharmaceuticals containing botulinum toxin for use in the treatment of facial wrinkles; medicated skin care preparations for medical purposes; syringes sold filled with botulinum purposes for treating facial wrinkles for medical purposes; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for use in the treatment of excessive sweating; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for use in the treatment of excessive eye blinking; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for use in the treatment of neuropathy pain; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for use in the treatment of facial wrinkles; pre-filled syringes sold filled with botulinum purposes for use in the treatment of excessive sweating for medical purposes; pre-filled syringes sold filled with botulinum purposes for use in the treatment of excessive eye blinking for medical purposes; pre-filled syringes sold filled with botulinum for use in the treatment of neuropathy pain for medical purposes; pre-filled syringes sold filled with botulinum purposes for use in the treatment of facial wrinkles for medical purposes; acne treatment preparations; gels, creams and solutions for dermatological use; medicated preparations for skin treatment; synthetic peptides for the treatment of facial wrinkles for pharmaceutical purposes; medical preparations for slimming purposes; nutraceuticals for use as a dietary supplement; surgical implants comprising living tissue grown from stem cells; tissues impregnated with pharmaceutical lotions for sunburn; tissues impregnated with pharmaceutical lotions for skin conditions; tissues impregnated with pharmaceutical lotions for treating eczema; tissues impregnated with pharmaceutical lotions for preventing diaper rash; medicinal preparations for stimulating hair growth; hypoglycemic agents; medicines for human purposes for use in the treatment of excessive sweating; medicines for human purposes for use in the treatment of excessive eye blinking; medicines for human purposes for use in the treatment of neuropathy pain; medicines for human purposes for use in the treatment of facial wrinkles

Promoting the goods and services of others by means of operating an on-line comprehensive shopping mall with links to the retail web sites of others; business intermediary services relating to mail order by telecommunications, namely, mail order services featuring cosmetics; import-export agency services; commercial administration of the licensing of the goods and services of others; electronic processing of orders for others; wholesale store services featuring cosmetics; retail store services featuring cosmetics; wholesale store services featuring injectable dermal fillers; retail store services featuring injectable dermal fillers; wholesale store services featuring pharmacological preparations for skin care; retail store services featuring pharmacological preparations for skin care; wholesale store services featuring medicines for human purposes; retail store services featuring medicines for human purposes; wholesale store services featuring synthetic peptides for pharmaceutical purposes; retail store services featuring synthetic peptides for pharmaceutical purposes; wholesale store services featuring artificial implants for skin regeneration; retail store services featuring artificial implants for skin regeneration; wholesale store services featuring medical apparatus for injecting fillers; retail store services featuring medical apparatus for injecting fillers

Medical apparatus for injecting fillers, namely, injection needles and guns for medical use for injecting dermal fillers sold empty; medical apparatus for injecting fillers, namely, medical syringes for injecting dermal fillers sold empty; medical apparatus for skin wrinkle removal, namely, injection needles and guns for medical use for injecting dermal fillers and botulinum toxin sold empty; medical apparatus for skin wrinkle removal, namely, medical syringes for injecting dermal fillers and botulinum toxin sold empty; skin regeneration therapy apparatus, namely, apparatus for the regeneration of skin stem cells for medical purposes; medical skin care apparatus, namely, skin moisture analyzers for medical purposes; medical skin care apparatus, namely, phototherapeutic apparatus for medical purposes in the nature of a LED (light-emitting diode) light source for medical and aesthetic skin treatments; medical apparatus and instruments other than for dental purposes, namely, injection needles and guns for medical use for injecting dermal fillers sold empty; medical apparatus and instruments other than for dental purposes, namely, medical syringes for injecting dermal fillers sold empty; syringes for medical purposes; hypodermic syringes; disposable syringes; injection device for pharmaceuticals; syringes for medical purposes, in the shape of pens; implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for facial wrinkles; artificial implants for skin regeneration, namely, implantable skin regeneration drug delivery ports; bone void fillers comprised of artificial materials; biodegradable implants, namely, biodegradable implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for regeneration of skin cells; gel-type implants comprised of artificial materials for filling wounds and lips, contouring the face and body, and skin rejuvenation; medical gel-type implants comprised of artificial materials used for wrinkle and scar treatment, lip, face, body contour and skin regeneration, in particular disposable syringes; esthetic facial massage apparatus for skin whitening effect; apparatus for acne treatment; machines and apparatus for hair growth functional scalp treatments, namely, medical apparatus for promoting hair growth; high frequency electromagnetic therapy apparatus

Filing History

FINAL DISPOSITION NOTICE SENT TO IB
Jul 11, 2026 FICS
FINAL DISPOSITION PROCESSED
Jul 11, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 30, 2026 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 22, 2026 ADCH
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 30, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 30, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 14, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 14, 2025 TROA
REFUSAL PROCESSED BY IB
Sep 5, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 19, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 19, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 16, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jul 15, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 2, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 9, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 9, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 6, 2025 REPR